Company / Revenue
Insulet Corporation Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$2.7B
FY2025
5-year range
$738.2M / $2.7B
FY2021-FY2025
Trend
+30.7%
vs FY2024
Sector context
#70 of 156
Health Care
What the data says
At $2.7B, Insulet Corporation's revenue ranks #70 of 156 in the Health Care sector. Revenue has increased for 6 consecutive years, from $464M in FY2019 to $2.7B in FY2025.
Based on SEC 10-K filings.
$2.7B in FY2025 with a 5-year CAGR of +36.9%.
Improved from $1.7B to $2.7B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +44.1%
- 5-Year CAGR
- +36.9%
- 10-Year CAGR
- -
Sector benchmark
#70 of 156 in Health CareTop 45% of 156This company $2.7B Sector average $19.0B
▼
-85.7% below sector average
Key checks
Key Insights
- Insulet Corporation's revenue has grown for 6 consecutive years.
- 5-year CAGR of +36.9%, indicating consistent growth.
- In FY2025, revenue increased 30.7% year-over-year.
- Ranks #70 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.7B | +30.7% |
| FY2024 | $2.1B | +22.1% |
| FY2023 | $1.7B | +87.6% |
| FY2022 | $904.4M | +22.5% |
| FY2021 | $738.2M | +30.9% |
| FY2020 | $563.8M | +21.6% |
| FY2019 | $463.8M | -17.7% |
| FY2018 | $563.8M | +21.6% |
| FY2017 | $463.8M | +26.4% |
| FY2016 | $367.0M | +39.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026